JASPER THERAPEUTICS INC (JSPR) Stock Analyst Earnings Estimates
NASDAQ:JSPR - Nasdaq - US4718712023 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A -66.81% | N/A 187.19% | N/A 1,028.82% | N/A 215.12% | N/A 109.01% | N/A 60.51% | N/A 32.42% | ||||||
| EBITDA YoY % growth | N/A | N/A | -36.456M | -50.221M -37.76% | -67.753M -34.91% | N/A -26.73% | N/A -12.53% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.71M | -20.683M -339.13% | -36.833M -78.08% | -51.196M -38.99% | -68.861M -34.50% | N/A -4.81% | N/A -18.76% | N/A -27.25% | N/A -35.57% | N/A 14.70% | N/A 35.95% | N/A 150.45% | N/A 614.84% | N/A 72.21% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -10.30 55.00% | -6.20 39.81% | N/A 24.88% | N/A -0.08% | N/A -12.20% | N/A -46.96% | N/A -40.81% | N/A -1.89% | N/A 31.73% | N/A 261.79% | N/A 63.48% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.26 15.92% | -1.27 -23.61% | -1.29 -32.53% | -1.38 -11.09% | -1.45 -14.63% | -0.89 30.30% | -0.93 27.80% | -0.95 31.14% | -0.98 32.27% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.83M -17.52% | -21.207M -40.70% | -22.411M -40.13% | -25.023M -25.81% | -25.625M -23.02% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.24 22.50% | -1.09 | -0.15 | -13.47% |
| Q2 2024 Q2Q % growth | -0.97 35.33% | -1.11 | 0.14 | 12.67% |
| Q1 2024 Q2Q % growth | -1.03 35.63% | -1.25 | 0.22 | 17.57% |
| Q4 2023 Q2Q % growth | -1.50 58.33% | -1.65 | 0.15 | 8.94% |
| Q3 2023 Q2Q % growth | -1.60 50.00% | -1.58 | -0.02 | -1.04% |
| Q2 2023 Q2Q % growth | -1.50 48.28% | -1.53 | 0.03 | 1.83% |
| Q1 2023 Q2Q % growth | -1.60 -166.67% | -1.66 | 0.06 | 3.41% |
| Q4 2022 Q2Q % growth | -3.60 54.43% | -3.67 | 0.07 | 1.96% |
| Q3 2022 Q2Q % growth | -3.20 84.24% | -3.49 | 0.29 | 8.40% |
| Q2 2022 Q2Q % growth | -2.90 | -3.20 | 0.30 | 9.26% |
| Q1 2022 Q2Q % growth | -0.60 | -3.57 | 2.97 | 83.19% |
| Q4 2021 Q2Q % growth | -7.90 | -3.50 | -4.40 | -125.48% |
| Q3 2021 Q2Q % growth | -20.30 | -2.82 | -17.48 | -620.43% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.03% | -3.65% | 0% | -10.8% |
| Revenue | N/A | N/A | N/A | N/A |